Olive passes $4B valuation with new funding round
Olive, which automates redundant tasks in healthcare, recently raised $400 million in a funding round. Since the start of the pandemic, the company has raised a total of $832 million.
Category: Columbus
Olive, which automates redundant tasks in healthcare, recently raised $400 million in a funding round. Since the start of the pandemic, the company has raised a total of $832 million.
Scientists at The Ohio State University are developing a cell therapy intended to regrow brain tissue damaged from ischemic stroke. Results from a study in mice were published in the journal Science Advances.